Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. in vitro cytotoxicity
Show results for
Products
Services

Companies

News
Articles

Refine by
Date

  • Older

In Vitro Cytotoxicity Articles & Analysis

5 news found

CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles   

CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles  

In collaboration with renowned research institutions, CD Formulation has created an in vitro cytotoxicity testing platform specifically designed for microspheres and microneedles. ...

ByCD Formulation


CD Formulation Empowers High-volume Manufacturing of Microspheres

CD Formulation Empowers High-volume Manufacturing of Microspheres

In addition to microsphere mass production, CD Formulation has expanded its expertise to include analytical testing, formulation development, stability testing, in vitro cytotoxicity testing, and ...

ByCD Formulation


CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

Microspheres & Microneedles In Vitro Release TestingThe microsphere and microneedle in vitro release test provided by CD Formulation is to test and evaluate the release amount and release rate of the drug within a certain period of time after administration, and to investigate the release behavior of the drug carrier. In Vitro ...

ByCD Formulation


Obsidian Therapeutics To Present Preclinical Data From cytoTIL15 Program at the European Society for Medical Oncology Congress 2021

Obsidian Therapeutics To Present Preclinical Data From cytoTIL15 Program at the European Society for Medical Oncology Congress 2021

The abstract for the poster describes how Obsidian’s cytoTIL15 product (TIL engineered with membrane-bound IL15, or mbIL15) demonstrates enhanced in vitro potency and phenotype and in vivo persistence in the absence of IL-2, paving the way for more durable efficacy and improved safety in patients with solid tumor malignancies. ...

ByObsidian Therapeutics, Inc.


AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

Elastic, biocompatible and resistant The newly synthesized polymers are tested for in vitro cytotoxicity at the NMI in Reutlingen according to DIN EN ISO 10993-5. ...

ByAdjuCor GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT